HiCM-388

N/A

Report date: 2025/10/21 17:28:52

Base Information

Drug NameHiCM-388
Drug Alias NameHiCM388HiCM-388
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsST Elevation Myocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesElpu Regenerative Medicine Technology (Shenzhen) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesElpu Regenerative Medicine Technology (Shenzhen) Co Ltd
Inactive CompaniesN/A
Active IndicationsST Elevation Myocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A